Japan Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size, Share and Forecast 2019-2025
Japan digital PCR (dPCR) and
real-time PCR (qPCR) market is expected to grow at a CAGR of 8.2% during the
forecast period. Japan has a significant growth in the dPCR and qPCR market
owing to the increase in the prevalence of infectious disease and development
in healthcare infrastructure. Among major global economies, Japan has the
highest percentage of the geriatric population. Various cancers are more
commonly found in the elderly age group. For instance, colon cancer accounts
for more than 90% of individuals diagnosed over the age of 50. Similarly,
stomach cancer accounts for about 60% of those diagnosed are over the age of
60. Cancer is one of the leading causes of death in Japan and the mortality
rate is increasing since the last 30 years in the country as per the Japanese
government. For instance, according to the World Health Organization (WHO),
Japan recorded 883,395 new cancer cases in 2018. This leads to the adoption of
dPCR and qPCr-based assays to detect mutations in a DNA region that is
associated with many cancer types.
To Request a Sample of our
Report on Japan Digital PCR (dPCR) and Real-Time PCR (qPCR) Market: https://www.omrglobal.com/request-sample/japan-digital-pcr-and-real-time-pcr-market
The
presence of some crucial players such as Takara Bio, Inc., Qiagen N.V., Thermo
Fisher Scientific Inc., and among others is estimated to be some of the major
factors that are propelling the growth of the market. Further, strategic
initiatives of players such as mergers, acquisitions, and product launches are
also estimated to contribute towards the growth of the market. For instance, in
January 2019, Abbott Laboratories announced that it has entered into an
eight-year partnership agreement with the Japanese Red Cross Society (JRC).
Under this agreement, Abbott is an exclusive supplier of serological
instrumentation, tests, and consumables used for blood and plasma screening in
Japan. The JRC screens approximately 5 million blood donations each year
enabling ensure a safe supply of products needed for blood transfusions and
plasma therapies. Abbott's broad portfolio of products is used to screen more
than 60% of the world's blood and plasma supply. This development aids Abbott
to strengthen its position and increase its revenue base in the Japanese
market.
(Get 15% Discount on Buying this Report)
A full Report of Japan
Digital PCR (dPCR) and Real-Time PCR (qPCR) Market is Available at: https://www.omrglobal.com/industry-reports/japan-digital-pcr-and-real-time-pcr-market
Japan dPCR and
qPCR Market Segmentation
By
Technology
·
Quantitative PCR (qPCR)
·
Digital PCR (dPCR)
By Product
·
Reagents and Consumables
·
Instruments
·
Software
By Application
·
Research Application
·
Clinical Application
·
Forensic Application
Company Profiles
·
Abbott Laboratories, Inc.
·
Agilent Technologies, Inc.
·
BioMérieux S.A.
·
Bio-Rad Laboratories, Inc.
·
Eppendorf AG
·
JN Medsys
·
Promega Corp.
·
Qiagen N.V.
·
Takara Bio Inc.
·
Thermo Fisher Scientific Inc.
Reasons
to buy from us –
1.
We cover more than 15 major industries, further segmented into more than 90
sectors.
2.
More than 120 countries are for analysis.
3.
Over 100+ paid data sources mined for investigation.
4.
Our expert research analysts answer all your questions before and after
purchasing your report.
For
More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/japan-digital-pcr-and-real-time-pcr-market
About Orion
Market Research
Orion Market Research (OMR) is a market research and consulting
company known for its crisp and concise reports. The company is equipped with
an experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment